Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
CARLSBAD, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) today announced its financial results for the quarter ended June 30, 2009. During 2009 Isis has continued to successfully execute its business strategy and as a result reported $669...
July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
Food Storage Safety: Tips to Avoid Food Poisoning
ROCHESTER, Minn., July 22 /PRNewswire-USNewswire/ -- Here are highlights
from the July issue of Mayo Clinic Women's HealthSource . You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource ...
July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair
Studies Show a Sunny Outlook is Good for Health, Longer Life
ROCHESTER, Minn., July 22 /PRNewswire-USNewswire/ -- Here are highlights
from the July issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo...
June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates
ROCHESTER, Minn., July 7 /PRNewswire-USNewswire/ -- Here are highlights
from the June issue of Mayo Clinic Women's HealthSource . You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required. Reprinting is allowed for a fee. Include the follow...
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
NEW ORLEANS and CARLSBAD, Calif., June 9 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today that Isis' antisense drugs were highlighted with eight presentations (including three oral talks and two late-breaking posters) during the American Diabetes Association's...
Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
- 71% Objective Tumor Response in Combination with Docetaxel in Advanced Breast Cancer -
- 65% Objective Tumor Response in Combination with Carboplatin/Paclitaxel in Advanced Lung Cancer -
- 64% Objective Tumor Response in Combination with Carboplatin/Paclitaxel in Advanced Breast Cance...
Bionovo Announces First Quarter 2009 Highlights and Financial Results
EMERYVILLE, Calif., May 7 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ) today announced first quarter highlights
and financial results for the three months ended March 31, 2009.
Bionovo presented data on a preclinical anti-cancer drug candi...
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting
FT. LAUDERDALE, Fla., May 7 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today presented results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) Phase 3 pivotal clinical studies using the Conjunctival Allergen Challenge (CAC) model of allergic c...
Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
BALTIMORE, April 27 /PRNewswire/ -- Global progress toward a malaria vaccine is among the key topics to be presented at the 12th Annual Conference on Vaccine Research (ACVR), sponsored by the National Foundation for Infectious Diseases (NFID) April 27-29, 2009 in Baltimore. The ACVR is the world's...
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
Final results from three large PEGINTRON(TM) clinical studies address key questions in the treatment of hepatitis C
COPENHAGEN, Denmark, April 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today reported that final results of three large PEGINTRON(TM) (peginterferon ...
AACR Data Highlights InNexus Preclinical Antibody Candidate
- Additional Presentations Underscore Potency, Binding Capabilities for Antibody Pipeline And Novel Technologies -
SCOTTSDALE, Ariz., April 9 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock Exchange: IXS.V, http://www.ixsbio.com ), a drug development company commercializi...
March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots
ROCHESTER, Minn., March 10 /PRNewswire-USNewswire/ -- Here are highlights
from the March issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscri...
February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus
Diabetes and Heart Disease: Risk Intertwined
ROCHESTER, Minn., Feb. 4 /PRNewswire-USNewswire/ -- Here are highlights
from the February issue of Mayo Clinic Women's HealthSource . You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required...
Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
MINNEAPOLIS, Jan. 13 /PRNewswire-FirstCall/ - - Uroplasty, Inc. (Amex: UPI ) highlighted results from a clinical study of Macroplastique for the treatment of female stress urinary incontinence, now available in the January 2009 Journal of Urology . This is the first, large, multicenter rando...
Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
SAN FRANCISCO, Dec. 7 /PRNewswire-USNewswire/ -- The largest study ever to examine the preventive use of blood-thinning medication to help prevent deadly blood clots in patients with cancer undergoing chemotherapy will be presented in a press conference on Sunday, December 7, at 9:30 a.m., during ...
Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Leaders of Schering-Plough Corporation (NYSE: SGP ) today provided an update for investors on the company's research pipeline, highlighting a rich and innovative portfolio that includes 46 new entities in clinical trials or under regulatory rev...
Symposium Highlights Yale Study Indicating Role of AHCC(R) for Immune System Enhancement and as a Promising Cancer Preventative
Significant Research Presented at the AHCC International Research Symposium
PURCHASE, N.Y., Sept. 16 /PRNewswire/ -- The 16th International AHCC(R)
(Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on
July 26th and 27th. The Symposium hosted by the AHCC Research Associatio...
September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
Cataract Removal - New Choices for This Common and Successful Surgery
ROCHESTER, Minn., Sept. 2 /PRNewswire-USNewswire/ -- Here are
highlights from the September issue of Mayo Clinic Health Letter. You may
cite this publication as often as you wish. Reprinting is allowed for a
fee. Mayo Clin...
Cardium Reports on Second Quarter 2008 Highlights and Financial Results
SAN DIEGO, Aug. 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics
(Amex: CXM ) today reported recent highlights
and developments, as well as
financial results for its second quarter ended June 30, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO )
August 2008 Mayo Clinic Women's HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam
ROCHESTER, Minn., Aug. 6 /PRNewswire-USNewswire/ -- Here are highlights
from the August issue of Mayo Clinic Women's HealthSource. You may cite
this publication as often as you wish. Mayo Clinic Women's HealthSource
attribution is required. Reprinting is allowed for a fee. Include the
Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
Data Support Prognostic Value of Circulating Tumor Cells
RARITAN, N.J., July 25 /PRNewswire/ -- An international, prospective
clinical trial found the number of circulating tumor cells (CTCs) is a
strong indicator of progression-free and overall survival among metastatic
colorectal cancer pa...
Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
PRINCETON, N.J., July 10 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX ) today provided a detailed overview of the company's
strategy, strength in research discovery and antibody development, and the
multiple opportunities Medarex is engaged in for creating long-term value.
June 2008 Mayo Clinic Women's HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing
ROCHESTER, Minn., June 24 /PRNewswire-USNewswire/ -- Here are
highlights from the June issue of Mayo Clinic Women's HealthSource. You may
cite this publication as often as you wish. Mayo Clinic Women's
HealthSource attribution is required. Reprinting is allowed for a fee.
Include the following...
New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
MARIETTA, Ga., June 17 /PRNewswire/ -- Solvay Pharmaceuticals, Inc.
announced today that a new analysis of pivotal study data conducted by the
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
showed that initial treatment response of hypogonadal men with AndroGel(R)
Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
- Oral presentation on the potent blood glucose lowering effect of SGLT2 antisense inhibitors in multiple preclinical models
- Eight additional presentations highlight significant activity in eight new metabolic disease targets utilizing antisense
SAN FRANCISCO and CARLSBA...
Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
Leading Urologist Presents OrBIT Study Results Comparing Percutaneous
Tibial Nerve Stimulation with Pharmaceutical Therapy at the 2008 American Urological Association Annual Meeting
MINNEAPOLIS, May 21 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex:
UPI), a medical device co...
Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
MONTVALE, N.J., May 16 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY ) today announced progress with several key development
programs at its R&D Day meeting with the investment community. The Company
reported new clinical data for MEM 1414, its lead PDE4 inhibitor,
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
KENILWORTH, N.J., May 15 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP ), a leader in advancing the science and treatment of
chronic hepatitis C virus (HCV) infection, announced today that data from
several clinical studies with PEGINTRON(TM) (peginterferon alfa-2b) and
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
KENILWORTH, N.J., April 17 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP ), a leader in advancing the science and treatment of
chronic hepatitis C virus (HCV) infection, announced today that final
results of the IDEAL study as well as from several other clinical studies
Sarasota's Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimer's Disease Research
Third-Party Japanese Study Suggests Drug Improves Memory
SARASOTA, Fla., Dec. 14 /PRNewswire/ -- The Roskamp Institute today
announced that its promising new drug application for the treatment of
Alzheimer's disease has received positive validation from an independent
human clinical st...
Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
NEW ORLEANS, Nov. 12 /PRNewswire/ -- Two studies being presented at the
American Academy of Ophthalmology's 2007 Annual Meeting suggest that
telemedicine may have a significant role to play in the diagnosis of eye
diseases, increased patient compliance and patient access to quality care. In t...
Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
MONTVALE, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Synvista Therapeutics,
Inc. (Amex: SYI ) announces results of a clinical trial known as the ICARE
study, being presented today at the American Heart Association's (AHA)
Scientific Sessions 2007 in Orlando, Florida. The study demonstrated that
Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
KENILWORTH, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Leading researchers
will present 68 data presentations involving Schering-Plough's hepatitis
products, including PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R)
(ribavirin, USP) combination therapy, a current standard of care in the
Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
PLYMOUTH MEETING, Pa., Oct. 25 /PRNewswire-FirstCall/ -- Genaera
Corporation (Nasdaq: GENR ) is providing the following summary of highlights
related to the successful first Phase 1 study of trodusquemine and
additional preclinical data expanding the support for selectivity and
President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign
Agency's Pro Bono Initiative Aims to Mobilize $25 Million to Eliminate Diseases of Poverty Afflicting the Poorest of the Poor
EAST RUTHERFORD, N.J., Oct. 17 /PRNewswire-USNewswire/ -- MWW Group
(http://www.mww.com ), one of the nation's top ten public relations firms, was
Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
TAXUS(R) Stent shows no additional very late stent thrombosis
NATICK, Mass. and VIENNA, Austria, Sept. 4 /PRNewswire-FirstCall/ --
Boston Scientific Corporation (NYSE: BSX ) today announced five-year and
final results from its TAXUS II clinical trial, demonstrating continued
Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
BERKELEY HEIGHTS, N.J., March 12 /PRNewswire-FirstCall/ -- Genta
Incorporated (Nasdaq: GNTA ) today announced financial results and progress
for the quarter and year ended December 31, 2007. The Company noted
significant recent milestones, including:
-- AGENDA Phase 3 trial using key b...
Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
-- New Phase 3 trial of Genasense(R) seeks to confirm benefit in melanoma -- New IND filed for clinical-stage product to treat bone disease
-- Company regains compliance for NASDAQ Global Markets listing; Genta common stock to resume trading under "GNTA" symbol in August 2007
Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data
Selected for Scientific Highlights Program at the American Academy
of Neurology Meeting
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Mar 19, 2007 - Acorda
Therapeutics (Nasdaq: ACOR) today announced that Andrew Goodman,
M.D., Director of the Multiple Sclerosis Center at the University
of Rochester, will present data from Acorda's MS-F203 Phase 3
clinical trial of Fampridine-SR in multiple sclero...
Ascenta Therapeutics Highlights Multiple Data Presentations at
Upcoming AACR Annual Meeting
SAN DIEGO--(BUSINESS WIRE)--Apr 13, 2007 - Ascenta Therapeutics,
Inc. announced today that its small molecule portfolio of
apoptosis-triggering compounds will be featured in three oral
presentations and several poster presentations at next week's 2007
Annual Meeting of the American Association for ...